Potential COVID-19 drug azithromycin may increase risk for cardiac events

Azithromycin — a commonly-prescribed antibiotic — also is being investigated as a potential treatment for COVID-19. Researchers have found that azithromycin by itself is not associated with an increase in cardiac events; however, if the drug is taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increased.

Source: Potential COVID-19 drug azithromycin may increase risk for cardiac events